Background: To evaluate the protective effect of oil (NSO) on the myocardium in streptozotocin-induced diabetic rats.
Materials And Methods: Thirty-two 7-8-week-old female Wistar albino rats (300-350 g) were equally divided into 4 groups: nondiabetic untreated animals (control), diabetes mellitus (DM), NSO, and DM+NSO groups. For the induction of diabetes, 45 mg/kg streptozotocin was applied to the rats in the DM and DM+NSO groups as a single intraperitoneal dose. NSO (400 mg/kg) was orally administered through an intragastric catheter once a day over 21 days. Formalin-fixed, paraffin-embedded tissue sections of the myocardium were evaluated histopathologically and immunohistochemically.
Results: Compared to the control, NSO, and DM+NSO groups, the myocardial tissue samples from the rats in the DM group had significantly higher myositis, hyaline degeneration, and Zenker's necrosis. Moreover, the Bcl-2 expressions were significantly higher in the control, NSO, and DM+NSO groups than in the DM group.
Conclusion: NSO has a protective effect on the myocardium of streptozotocin-induced diabetic rats, most likely via suppressing apoptosis.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992396 | PMC |
http://dx.doi.org/10.4183/aeb.2019.289 | DOI Listing |
BMJ Open Diabetes Res Care
June 2022
Department of Nervous Diseases and Neurosurgery, Sechenov University, Moskva, Russian Federation.
Introduction: Antioxidants may have positive impact on diabetic polyneuropathy (DPN), presumably due to alleviation of oxidative stress. We aimed to evaluate the efficacy and safety of combination of antioxidants: succinic acid, inosine, nicotinamide, and riboflavin (SINR) in the treatment of DPN.
Research Design And Methods: In a double-blind, placebo-controlled clinical trial, men and women aged 45-74 years with type 2 diabetes and symptomatic DPN, with initial Total Symptom Score (TSS) ˃5, were randomized into experimental (n=109) or placebo (n=107) group.
Anim Biotechnol
December 2022
Department of Animal and Veterinary Sciences, College of Agricultural and Marine Sciences, Sultan Qaboos University, Muscat, Sultanate of Oman.
This study was conducted to examine the effects of neem () seed oil (NSO) on feed intake, ruminal fermentability, feed digestibility, nitrogen balance, and blood parameters in Omani sheep. Nine Omani male sheep (BW; 54.44 ± 8 kg/sheep) were used in a replicated 3 × 3 Latin Square design with three dietary treatments and three periods, with each period lasting 21 days.
View Article and Find Full Text PDFNeurotoxicology
July 2020
Addictovigilance Centre of Paris, GH Lariboisiere-Fernand Widal, Saint Louis AP-HP, France.
Among the expanding world of New Psychoactive Substances (NPS), Designer Medicines (DM) are designed to mimic psychoactive drugs and might lead to adverse events of various severity. The DM category includes designer benzodiazepines (DB), phenmetrazine, modafinil, methylphenidate analogs, and novel synthetic opioids (NSO). To investigate DM-related complications in France, all data on NPS collected in the French Addictovigilance network database through spontaneous reports (SRs) and the annual survey on deaths related to the abuse of licit and illicit psychoactive substances (DRAMES survey) between 2009 and 2017 were analyzed.
View Article and Find Full Text PDFActa Endocrinol (Buchar)
January 2019
Ataturk University - Faculty of Veterinary Medicine, Dept. of Pathology, Erzurum, Turkey.
Background: To evaluate the protective effect of oil (NSO) on the myocardium in streptozotocin-induced diabetic rats.
Materials And Methods: Thirty-two 7-8-week-old female Wistar albino rats (300-350 g) were equally divided into 4 groups: nondiabetic untreated animals (control), diabetes mellitus (DM), NSO, and DM+NSO groups. For the induction of diabetes, 45 mg/kg streptozotocin was applied to the rats in the DM and DM+NSO groups as a single intraperitoneal dose.
Nat Med
June 2019
Department of Pathology, School of Medicine, Stanford University, Stanford, CA, USA.
It is estimated that 350 million individuals worldwide suffer from rare diseases, which are predominantly caused by mutation in a single gene. The current molecular diagnostic rate is estimated at 50%, with whole-exome sequencing (WES) among the most successful approaches. For patients in whom WES is uninformative, RNA sequencing (RNA-seq) has shown diagnostic utility in specific tissues and diseases.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!